Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05722873 · ClinicalTrials.gov registry record · NA

The Metabolic Effects of Intermittent Fasting

A NA study of Normal and Overweight Individuals at High-risk of Diabetes, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05722873 is a NA study of Normal and Overweight Individuals at High-risk of Diabetes that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05722873, a NA study of Normal and Overweight Individuals at High-risk of Diabetes, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Caloric restriction has beneficial metabolic effects in humans including weight loss and improvement in blood pressure and lipid levels. Intermittent fasting has emerged as a popular alternative to caloric restriction as it does not require daily adherence to a dietary protocol, but whether the benefits of fasting protocols are dependent on weight loss is not known. In this study, the investigators will explore the metabolic effects of fasting and evaluate whether these effects, including negative effects on bone metabolism, are independent of weight loss.

Interventions

  • BEHAVIORAL Fasting arm
  • BEHAVIORAL Weight maintenance
  • BEHAVIORAL Counseling

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-10-25
Est. Completion 2028-06-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05722873

The ClinicalTrials.gov registry entry for NCT05722873 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Normal and Overweight Individuals at High-risk of Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Fasting arm is the first listed.

NCT05722873 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05722873 about?

NCT05722873 is a clinical study titled "The Metabolic Effects of Intermittent Fasting". Caloric restriction has beneficial metabolic effects in humans including weight loss and improvement in blood pressure and lipid levels. Intermittent fasting has emerged as a popular alternative to caloric restriction as it does not require daily adherence to a dietary protocol, but whether the bene...

What is the current status of trial NCT05722873?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-10-25. Estimated completion is 2028-06-30.

What conditions does trial NCT05722873 study?

This clinical trial studies the following conditions: Normal and Overweight Individuals at High-risk of Diabetes.

What interventions are being tested in trial NCT05722873?

The interventions under investigation include: Fasting arm (BEHAVIORAL), Weight maintenance (BEHAVIORAL), Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT05722873?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05722873 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.